T1	Participants 147 178	patients with limited prognosis
T2	Participants 389 426	patients with limited life expectancy
T3	Participants 528 567	patients in the palliative care setting
T4	Participants 1097 1140	conducted from June 3, 2011, to May 2, 2013
T5	Participants 680 958	Eligibility included adults with an estimated life expectancy of between 1 month and 1 year, statin therapy for 3 months or more for primary or secondary prevention of cardiovascular disease, recent deterioration in functional status, and no recent active cardiovascular disease
T6	Participants 1627 1653	381 patients were enrolled
